https://seekingalpha.com/article/4385504-teva-pharmaceutical-industries-ltd-teva-ceo-kare-schultz-on-q3-2020-results-earnings-call?source=feed_tag_israel
Nov 05, 2020 - Teva Pharmaceutical Industries Ltd (NYSE:TEVA) Q3 2020 Earnings Conference Call November 05, 2020, 08:00 ET Company Participants Kevin Mannix - SVP, IR Kare Schultz - President, CEO & Director Eli Kalif - EVP & CFO Brendan O'Grady - EVP, North America Commercial Conference Call Participants Gregory Gilbert - Truist Securities Umer Raffat - Evercore ISI Aaron Gal - Sanford C.
0
sa:-3735158422858330323
0
https://seekingalpha.com/news/3619598-appeals-court-revives-235m-glaxo-verdict-against-teva?source=feed_sector_healthcare
Oct 02, 2020 -
0
sa:8088843928292458020
0
http://www.zacks.com/stock/news/1068692/abbvie-elezanumab-gets-fdas-fast-track-and-orphan-drug-tags?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1068692
Sep 29, 2020 - AbbVie's (ABBV) elezanumab is presently being evaluated in a phase II study for spinal cord injury.
zc:-7641480034797306968
0
https://www.fool.com/investing/2020/09/19/3-top-stocks-you-can-buy-and-hold-for-the-next-dec/?source=iedfolrf0000001
Sep 19, 2020 - Companies that are built to last are worth considering for your longer-term money, even amid a crisis.
0
fool:497040764097567864
0
http://www.zacks.com/stock/news/1057087/satsuma-plunges-on-disappointing-data-on-migraine-treatment?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1057087
Sep 11, 2020 - Satsuma (STSA) tanks as late-stage study of STS101 (dihydroergotamine [DHE] nasal) powder as an acute treatment for migraine disappoints.
zc:-5131839618460838392
0
https://seekingalpha.com/article/4372214-teva-charged-in-criminal-antitrust-investigation-what-means?source=feed_tag_israel
Sep 02, 2020 - One week ago, the DOJ charged Teva for overcharging customers in an alleged price-fixing conspiracy. In this article, I will take a closer look at what this lawsuit means for Teva.
0
sa:-6569256860114361365
0
https://seekingalpha.com/news/3568193-teva-launches-rituxan-biosimilar-in-u-s?source=feed_sector_healthcare
May 04, 2020 - Teva Pharmaceutical Industries (NYSE:TEVA) and collaboration partner Celltrion Healthcare announce the commercial availability of Truxima (rituximab-abbs), a biosimilar to Roche's (OTCQX:RHHBY) Rituxa
0
sa:8576551864079426018
0
http://www.zacks.com/stock/news/897134/teva-pharmaceutical-industries-ltd-teva-gains-as-market-dips-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-897134
Apr 28, 2020 - In the latest trading session, Teva Pharmaceutical Industries Ltd. (TEVA) closed at $10.84, marking a +1.12% move from the previous day.
zc:-5581795328544859861
0
https://seekingalpha.com/news/3565267-eagle-pharma-and-teva-prevail-in-bendeka-patent-challenge?source=feed_sector_healthcare
Apr 28, 2020 - Eagle Pharmaceuticals (NASDAQ:EGRX) and licensee Teva Pharmaceutical Industries (NYSE:TEVA) announce a favorable outcome in a patent dispute from would-be generic competitors to blood cancer med Bende
0
sa:5615583230953636508
0
https://seekingalpha.com/news/3564611-teva-launches-ajovy-autoinjector-in-u-s?source=feed_sector_healthcare
Apr 27, 2020 - Teva Pharmaceutical Industries (NYSE:TEVA) announces the availability of the autoinjector device for migraine med Ajovy (fremanezumab-vfrm) at a wholesale acquisition cost (WAC) of $603.20.The
0
sa:-2453459381287557889
0